- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Andrea Baer on the Non-Financial Restrictions That Influence Medication Adherence
There are non-financial barriers that contribute to why a patient does not adhere to their medications, according to Andrea Baer, director of Patient Advocacy for Mended Hearts.
There are non-financial barriers that contribute to why a patient does not adhere to their medications, according to Andrea Baer, director of Patient Advocacy for Mended Hearts.
Transcript (slightly modified)
What barriers other than financial ones are there that prevent patients from being adherent to their medications?
Everybody always thinks of money as a barrier, but if you are looking at non-financial barriers—if there is a transportation issue if you are in a rural community and can’t get to a specialty pharmacy or a compounding pharmacy and you can’t get the drug. If you can’t access the information about the drugs or if you have side effects of the drugs and you don’t understand them and you don’t know who to talk to for it to be resolved, then you may just stop taking the medication.
So, it’s not just about financial barriers, I think that there a multitude of social, emotional, and economic reasons that people don’t adhere to their medication.
Impact of Amivantamab-Lazertinib on EGFR, MET Resistance Alterations in NSCLC: Danny Nguyen, MD
September 15th 2025The combination of amivantamab and lazertinib in first-line non–small cell lung cancer (NSCLC) significantly reduces resistance mechanisms with implications for second-line treatment, said Danny Nguyen, MD, of City of Hope.
Read More
Disparities in Biomarker Testing Impact Nonsquamous NSCLC Outcomes: Surbhi Singhal, MD
September 6th 2025Surbhi Singhal, MD, of the University of California Davis, discussed disparities in biomarker testing among patients diagnosed with stage IV nonsquamous non–small cell lung cancer (NSCLC).
Read More
